Dietary Supplements in Adults taking Cardiovascular Drugs: A Comparative Effectiveness Review– Approximately 81 million American adults (one third of all adults) will have at least one form of cardiovascular disease (CVD) in their lifetime. The standard of care for this disease remains primarily pharmaceuticals coupled with certain lifestyle and dietary recommendations. The past few decades have seen a rise in the general use of complementary and alternative medicines (CAM) where approximately two-thirds of people suffering from CVD use dietary supplementation. These patients are then at risk for potential adverse events that can arise from interactions with prescribed medications. The Agency for Healthcare Research and Quality (AHRQ) devised a systematic review to synthesize and grade the strength of evidence of the advantages and disadvantages of adding dietary supplements to prescribed cardiovascular therapy.
Determine the benefits and harms of the concomitant use of complementary and alternative medicines in combination with cardiovascular drugs on the cardiovascular disease population.
Assess the use of specific dietary supplements on clinical cardiovascular effectiveness or efficacy outcomes.
Apply the AHRQ results to guide effective management of cardiovascular disease for shared decision making.
1.0 Free CEUs for Certified Case Managers
This course also offers 0.5 Free CEUs for Physicians, Nurse Practitioners, Nurses, and Pharmacists